Editorial
Published on 23 Nov 2023
Editorial: Advances in anti-malarial drug discovery
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1335842
- 2,078 views
- 2 citations
Type at least 3 characters
152 articles
articles
Original Research
Published on 22 Nov 2023
Targeting a cancer-specific LYPD3 glycoform for tumor therapy
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1298916
- 4,261 views
- 3 citations
Review
Published on 21 Nov 2023
Future treatments for the arteriopathy of ectopic calcification disorders
in Cardiovascular and Hematologic Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1249966
- 3,459 views
Original Research
Published on 14 Nov 2023
In vitro drug interaction of ionophores with artemisinin and chloroquine against Plasmodium falciparum 3D7 blood-stage infection
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1257698
- 2,497 views
- 1 citation
Original Research
Published on 30 Oct 2023
An improved method for large scale generation and high-throughput functional characterization of human iPSC-derived microglia
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1289314
- 4,133 views
Review
Published on 18 Sep 2023
State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approach
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1254656
- 3,710 views
- 7 citations
Mini Review
Published on 05 Sep 2023
Harnessing bioluminescence for drug discovery and epigenetic research
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1249507
- 5,051 views
- 5 citations
Brief Research Report
Published on 03 Aug 2023
Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1216516
- 6,377 views
- 6 citations
Review
Published on 25 Jul 2023
The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1237655
- 4,675 views
- 7 citations
Original Research
Published on 20 Jul 2023
9-PAHSA displays a weak anti-inflammatory potential mediated by specific antagonism of chemokine G protein-coupled receptors
in Anti-inflammatory and Immunomodulating Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1138461
- 4,226 views
- 1 citation
Review
Published on 13 Jul 2023
Targeting proteases and proteolytic processing of unusual N-terminal extensions of Plasmodium proteins: parasite peculiarity
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1223140
- 2,645 views
- 3 citations
Mini Review
Published on 12 Jul 2023
FAIR data management: what does it mean for drug discovery?
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1226727
- 3,870 views
- 9 citations
Original Research
Published on 07 Jul 2023
The tumor suppressor 5A2, a synthetic miR-7-5p mimic, targets oncogenic and metabolic pathways, as revealed by transcriptome-wide analysis
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1181637
- 2,313 views
Review
Published on 21 Jun 2023
Yin-yang in drug discovery: rethinking de novo design and development of predictive models
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1222655
- 6,959 views
- 5 citations
Original Research
Published on 15 Jun 2023
MMV006087 is a potent Malaria Box compound against Plasmodium falciparum clinical parasites
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1190471
- 3,232 views
- 2 citations
Review
Published on 01 Jun 2023
Lessons that can be learned from the SARS-CoV-2 pandemic and their impact on the prophylaxis and treatment development for neglected tropical arboviruses
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1176768
- 5,399 views
Mini Review
Published on 24 May 2023
Drug discovery and development: introduction to the general public and patient groups
in Technologies and Strategies to Enable Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1201419
- 205,343 views
- 164 citations
Review
Published on 10 May 2023
The critical role of mode of action studies in kinetoplastid drug discovery
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1185679
- 4,300 views
- 9 citations
Original Research
Published on 09 May 2023
Generation of a potent anti-PD-L1-CD47 bispecific antibody with a strong therapeutic and safety profile for cancer immunotherapy
in Anti-Cancer Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1182146
- 5,818 views
- 1 citation
Editorial
Published on 27 Feb 2023
Editorial: Development/repurposing of drugs to tackle the multiple variants of SARS-CoV-2
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1157688
- 1,553 views
- 2 citations
Brief Research Report
Published on 21 Feb 2023
Numaswitch, a biochemical platform for the efficient production of disulfide-rich pepteins
in Neurological Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1082058
- 4,314 views
- 1 citation
Original Research
Published on 10 Feb 2023
HMM-based profiling identifies the binding to divalent cations and nucleotides as common denominators of suramin targets
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1112992
- 2,329 views
Original Research
Published on 08 Feb 2023
Identification of novel genetic variants, including PIM1 and LINC01491, with ICD-10 based diagnosis of pulmonary arterial hypertension in the UK Biobank cohort
in Cardiovascular and Hematologic Drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1127736
- 5,148 views
- 9 citations
Original Research
Published on 20 Jan 2023
In silico identification of potential inhibitors of acyl carrier protein reductase and acetyl CoA carboxylase of Plasmodium falciparum in antimalarial therapy
in In silico Methods and Artificial Intelligence for Drug Discovery
Frontiers in Drug Discovery
doi 10.3389/fddsv.2023.1087008
- 4,397 views
- 9 citations